State Supports Universal Hepatitis B Vaccine Birth Dose
December 11, 2025
On December 5, the Advisory Committee on Immunization Practices (ACIP) voted to eliminate the universal hepatitis B vaccine recommendation for infants.
February 9 Noon-Time Forum to Look at SGLT2 Inhibitors
February 3, 2022
The MMA’s next noon-time forum will examine sodium-glucose cotransporter-2 (SGLT2) inhibitors, a new 'triple play' for diabetes, cardiovascular and kidney diseases. The forum will take place February 9 from noon to 1 p.m.
This forum will review the pharmacology of SGLT2 inhibitors and then discuss the role these drugs play in the management of type 2 diabetes. The evidence for improving cardiorenal outcomes will be presented and recommendations made for the use of these drugs in patients with cardiovascular or renal diseases. The session will conclude with a Q&A panel discussion.
The forum will be moderated by Andrew Olson, MD, and include Anne Bantle, MD, Prabhjot S. Nijjar, MD, and Mark Rosenberg, MD. All faculty for this forum are with the University of Minnesota Medical School.
Learning objectives for the forum include:
-
Describe the pharmacology of SGLT2 inhibitors and the use of these drugs in the management of type 2 diabetes mellitus.
-
Appraise the data supporting the cardiorenal protective effects of SGLT2 inhibitors.
-
Utilize SGLT2 inhibitors in the management of patients with diabetes, cardiovascular or kidney diseases.
To register, click here.
The forum is free to members, $15 for non-members. This forum is being held in partnership with the University of Minnesota.
Latest News
MMA Signs on to Bill to Ease Senior Access to Care
December 11, 2025
The MMA, along with other state medical associations and 75 specialty societies, signed on to a letter to Congressional leaders urging passage of the “Improving Seniors’ Timely Access to Care Act of 2025.”
Physicians Tackle Payment Reform, Public Health, and More at AMA Interim Meeting
December 11, 2025
Physicians from Minnesota and across the country gathered November 14-18 for the AMA 2025 Interim Meeting in National Harbor, Maryland, to address payment reform, public health challenges, rural healthcare, and the escalating administrative and financial pressures on medical practice.